相关实验视频
Updated: Jul 7, 2025
04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
956
抑制幸存者的同质化 降低神经母细胞瘤细胞生长
Carmen Dorneburg1, Celimene Galiger1, Giovanna L Stadler1
1Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, 89075 Ulm, Germany.
Cancers
|December 23, 2023
概括
抑制幸存者的同质化,而不是转录,有效地准神经母细胞瘤. 通过破坏细胞生长和分裂,LQZ-7I显示出治疗这种儿童癌症的前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 增加BIRC5/幸存者表达与神经母细胞瘤 (NB) 的预后不佳相关,神经母细胞瘤 (NB) 是一种常见的儿童癌症.
- 幸存者调节了线粒旋检查点,使其成为治疗目标.
- 目前正在研究生存抑制剂,包括转录抑制剂和同质化抑制剂.
研究的目的:
- 为了比较幸存者转录的遗传抑制与神经母细胞瘤中幸存者同质化抑制的疗效.
- 评估新型幸存者二分化抑制剂S12和LQZ-7I对神经母细胞瘤细胞和临床前模型.
主要方法:
- 产生了Birc5+/-/MYCNtg/+小鼠来研究幸存者转录的遗传抑制.
- 在实验室中对NB细胞进行了S12和LQZ-7I幸存者二分化抑制剂的测试,并在实验室中使用老鼠异种移植和胆膜 (CAM) 模型对NB细胞进行了实验.
- 评估了对细胞活力,克隆原性, anchorage-independent增长,线性线形成,瘤生长和出血的影响.
主要成果:
- 幸存者转录的遗传抑制并没有减弱小鼠中的NB攻击性.
- 在体外,S12降低了NB细胞的活力,克隆原性和固独立生长,并在体内减少了内出血.
- 在较低度下,LQZ-7I在体外显示出强大的疗效,废除NB细胞生长和扭曲线性;LQZ-7I在体内减少瘤大小和扩散,没有明显的毒性.
结论:
- 抑制幸存者的同质化,特别是使用LQZ-7I,是针对神经母细胞瘤的更有效的策略,而不是抑制其转录.
- 由于其在减少瘤生长和扩散方面的有效性,LQZ-7I在神经母细胞瘤治疗中显示出显著的治疗潜力.
- 需要进一步研究LQZ-7I作为神经母细胞瘤治疗的方法.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K